Cargando…
G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS-MAPK axis pathway
Glucose-6-phosphate dehydrogenase (G6PD) is crucial rate-limiting enzyme of the pentose phosphate pathway (PPP). G6PD dysregulation has been reported in various types of human cancer, and the role of G6PD in cancer progression was demonstrated in numerous studies. A previous study from our laborator...
Autores principales: | Zhang, Qiao, Han, Qiaoqiao, Yang, Zhe, Ni, Yueli, Agbana, Yannick Luther, Bai, Honggang, Yi, Zihan, Yi, Xiaojia, Kuang, Yingmin, Zhu, Yuechun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252464/ https://www.ncbi.nlm.nih.gov/pubmed/32319593 http://dx.doi.org/10.3892/ijo.2020.5041 |
Ejemplares similares
-
G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression
por: Zhang, Qiao, et al.
Publicado: (2022) -
NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
por: Zhang, Qiao, et al.
Publicado: (2020) -
Correction to: NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
por: Zhang, Qiao, et al.
Publicado: (2020) -
Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin‐related modifier 1 modification of glucose 6‐phosphate dehydrogenase
por: Ni, Yueli, et al.
Publicado: (2021) -
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma
por: Zhang, Qiao, et al.
Publicado: (2017)